Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Summary

The primary purpose of this study is to evaluate the antiviral activity of oral BTA-C585 compared to placebo in healthy volunteers after intranasal challenge with RSV-A Memphis 37b virus.

Timeline

Start

2016-03

Primary completion

2016-12

Completion

2016-12

Drugs

Indications